No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 43.1x · 10Y median 43.1x · 52nd percentile · as of Sep 10, 2026
Annualized revenue (TTM) · by quarter, last 15
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-12T00:15:10.081Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Astera Labs, Inc. Common Stock (ALAB) stock was $291.22 as of Sep 11, 2026, 4:00 PM EDT, up 2.35% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +23.5%
Astera Labs, Inc. develops, produces, and markets semiconductor-based connectivity solutions for cloud computing and artificial intelligence infrastructure.
Semiconductors · Santa Clara, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 3, 2026
52 days away
EPS Estimate
1.19
Revenue Est.
$550.62M
Last Quarter Results
EPS
$0.80
vs Estimate
$0.69
Revenue
TGMCharts Research notes tied to this stock's charts and claim ledger.
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ALAB | $49.92B | $291.22 | +2.35% | +23.53% | N/A | N/A | N/A |
| 2CIEN | $49.48B | $349.54 | +4.48% | +157.80% | +44.07% | +31.48% | vs ALAB |
| 3WDAY | $48.64B | $185.70 | +0.33% | -19.38% | -7.18% | +7.87% | vs ALAB |
| 4CRWV | $48.55B | $88.99 | -0.15% | -23.93% | N/A | N/A | vs ALAB |
| 5TEAM | $47.20B | $179.70 | +0.07% | -2.54% | -14.05% | +19.68% | vs ALAB |
| 6XYZ | $47.14B | $79.21 | +0.18% | +5.16% | -20.60% | +21.56% | vs ALAB |
28.93
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$392.40M
vs Estimate
$360.85M
Consensus Rating
Based on 23 analysts
Average Price Target
$389.95
+33.9% upside
Low
$190.00
Current
$291.22
High
$500.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.18 | $1.19 | $1.20 | 14 |
| Quarter ending Dec 2026 | $1.35 | $1.42 | $1.47 | 13 |
| Quarter ending Mar 2027 | $1.41 | $1.49 | $1.60 | 5 |
| Quarter ending Jun 2027 | $1.48 | $1.56 | $1.69 | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $3.91 | $3.99 | $4.10 | 14 |
| FY 2027 | $6.07 | $6.49 | $7.29 | 15 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $550.23M | $550.62M | $552.33M | 12 |
| Quarter ending Dec 2026 | $629.04M | $655.30M | $678.16M | 12 |
| Quarter ending Mar 2027 | $668.62M | $697.64M | $739.69M | 6 |
| Quarter ending Jun 2027 | $707.38M | $738.09M | $782.58M | 6 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.89B | $1.91B | $1.94B | 16 |
| FY 2027 | $2.98B | $3.08B | $3.40B | 18 |
